Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

URGENTE. H2020-SC1-BHC-07-2019 (Proyecto IMATE). Consorcio de institutos de investigación busca una pyme con experiencia en edición genética (miRNA, siRNA, CRISPR/Cas-9) y/o terapia celular

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDDE20190215001
Publicado:
18/02/2019
Caducidad:
22/02/2019
Resumen:
Un consorcio alemán busca una pyme con experiencia en edición genética mediante CRISPR, suministro de siRNA y experiencia preclínica en terapias celulares y materiales/hidrogeles inyectables con el fin de presentar una propuesta a la convocatoria H2020-SC1-BHC-07-2019 - Medicina regenerativa: desde nuevos conocimientos hasta nuevas aplicaciones. El objetivo del proyecto es desarrollar y probar nuevas herramientas y tecnologías que permitan la modulación de las propiedades funcionales de macrófagos y células T para facilitar la reparación de tejidos, reducir la fibrosis y acelerar la integración de tejidos y a la vez apoyar su funcionalidad. La fecha límite de la convocatoria es el 16 de abril de 2019 y el plazo para presentar expresiones de interés finaliza el 22 de febrero.

Details

Tittle:
URGENT | H2020-SC1-BHC-07-2019 - Project IMATE: Consortium of research institutes looking for an SME with expertise in the field of gene editing (miRNA,siRNA, CRISPR/Cas-9) and/or cell therapy
Summary:
The aim of the project is to develop and test new tools and technologies that enable modulation of the functional properties of macrophages and T cells to support tissue repair, reduce fibrosis and accelerate integration of engineered tissues while supporting their functionality. For this purpose the German consotium partner looks for a partner (SME) with expertise in gene editing using CRISPR, siRNA delivery and preclinical expertise in cell-based therapies and injectable materials/hydrogels.
Description:
The project IMATE will be submitted under the call H2020-SC1-BHC-07-2019 - Regenerative medicine: from new insights to new applications. Central premise of the project is that the pro-healing and regenerative potential of immune cells can be harnessed to promote tissue regeneration/healing and suppress fibrosis.
This will be achieved using a mix of gene editing and cell and growth factor delivery methods with a focus on the use of bio instructive materials.
Besides the German organisation the project consortium as it stands involves several research institutions from all over Europe (France, Germany, UK, Portugal, Spain, Turkey) that are searching for a collaboration with research-driven SMEs that will profit by the knowledge transfer and the generation of exploitable results. The expected demand for this SME is to be involved in the development of gene editing processes - using technologies like CRISPS/Cas-9 - and contribute to the goal of a cell therapy model and injectable materials/hydrogels.

Deadline for EOIS: 22 February 2019
Deadline for the call: 16 April 2019
Stage of Development:
Proposal under development
Technical Specification or Expertise Sought:
Specific technical requirements would involve the following:
- gene editing using CRISPR
- miRNA and siRNA delivery
- preclinical expertise in cell-based therapies and injectable materials/hydrogels
IPR Status:
Other

Partner sought

Partner Sought:
The partner may work within a workpackage that tackles gene editing approaches for immune modulation and work towards pre-clinical models of liver and kidney fibrosis.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Other
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German

Dissemination

Programme-call

Framwork Programme:
H2020
Evaluation Scheme:
Proposal procedure will be single-stage
Anticipated Project Budget:
Between 6 and 8 Mio. -Y-euro;
Coordinator Required:
No
Deadline for Call:
16/04/2019
Project title and Acronym:
Next Generation Tools For Immune Assisted Tissue Regeneration; Harnessing The Immune System To Promote Tissue Healing and Regeneration (IMATE)